Peter Waldron
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 5
- Genetics top 10%
- Hemoglobinopathies and Related Disorders 6
- Chronic Lymphocytic Leukemia Research 3
- Microbiology top 10%
- Reproductive tract infections research 2
-
- Complement system in diseases 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Chromatin Remodeling and Cancer 2
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- S. Christopher JonesBryan RodgersSusan Bersoff‐MatchaPage CrewLynne NeumayrElliott VichinskyPedro de AlarcónRichard B. Womer
- Cited by
- HematologyGeneticsMicrobiology
- Journals
- American Journal of Hematology (5 papers)Journal of Pediatric Hematology/Oncology (3 papers)Blood (2 papers)
- Partner nations
- United StatesCanadaLebanon
In The Last Decade
Peter Waldron
30 papers receiving 627 citations
Peers
Comparison fields: 5 of 75
- Hematology 169
- Genetics 145
- Microbiology 52
- Immunology 109
- Pathology and Forensic Medicine 79
Countries citing papers authored by Peter Waldron
This map shows the geographic impact of Peter Waldron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Waldron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Waldron more than expected).
Fields of papers citing papers by Peter Waldron
This network shows the impact of papers produced by Peter Waldron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Waldron. The network helps show where Peter Waldron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Waldron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 135 | |
| 4 | 2019 | 12 | |
| 5 | 2018 | 34 | |
| 6 | 2018 | 12 | |
| 7 | 2018 | 53 | |
| 8 | 2017 | 20 | |
| 9 | 2016 | 1 | |
| 10 | 2007 | 35 | |
| 11 | 2003 | 38 | |
| 12 | 2001 | 8 | |
| 13 | 1999 | 1 | |
| 14 | 1999 | 4 | |
| 15 | 1999 | 35 | |
| 16 | 1999 | 17 | |
| 17 | 1998 | 11 | |
| 18 | 1994 | 46 | |
| 19 | 1994 | 14 | |
| 20 | 1967 | 3 |
About Peter Waldron
Peter Waldron is a scholar working on Hematology, Genetics, Microbiology, Transplantation and Internal Medicine, having authored 30 papers that have together received 641 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Reproductive tract infections research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Chromatin Remodeling and Cancer (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Hematology (169 citations), Genetics (145 citations), Microbiology (52 citations), Immunology (109 citations) and Pathology and Forensic Medicine (79 citations). Peter Waldron has collaborated with scholars based in United States, Canada and Lebanon. Frequent co-authors include S. Christopher Jones, Bryan Rodgers, Susan Bersoff‐Matcha, Page Crew, Lynne Neumayr, Elliott Vichinsky, Pedro de Alarcón, Richard B. Womer, Mark A. Lovell and Ann N. Earles. Their work appears in journals such as American Journal of Hematology, Journal of Pediatric Hematology/Oncology, Blood, Clinical Infectious Diseases and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.